Join the Oncology Voice Network. Join for Free
Positive Mindset = Positive Outcomes
Positive mindset overcoming negativity bias mindfulness techniques mindset-driven recovery positive habits

Positive Mindset = Positive Outcomes


Share This Article


Summary

In this episode, Don Sandel from Go Positive joins Tom Caravela to explore the power of a positive mindset. They delve into the science behind positivity, introducing the DOSE acronym and discussing the effects of overcoming negativity bias. Don shares techniques for fostering positivity through relationships, self-talk, and mindfulness. The conversation includes practical tips on meditation, choosing happiness, and using technology and exercise to build positive habits. They emphasize the importance of accountability and a supportive social environment. The episode wraps up with inspiring stories of mindset-driven recovery and a note of gratitude.

This weeks MSL Talk podcast guest is Don Sandel, the Founder, speaker, and facilitator at GoPositiv and best-selling author and performance coach who shares research-based solutions for adopting a positive mindset which leads to positive outcomes.

Don shares…

👉 What led him to write his book “Positive Mindshift”
👉 What is most important for people when it comes to mindset
👉 How people can break the habit of negativity bias
👉 What ways we can shift our thoughts and retrain our brain
👉 What kind of daily habits and mindset techniques we can adopt each day

Click for Source
Positive mindset, overcoming negativity bias, mindfulness techniques, mindset-driven recovery, positive habits

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
Things will be HARD…but YOU can do hard things!
Partner Avatar MSL Talk: Tom Caravela

Things will be HARD…but YOU can do hard things!

Press Release
Visionaries Behind Oncology Voice Network: Dr. Ramin Farhood & Dr. Kirk Shepard
OVN Avatar OVN Staff

Visionaries Behind Oncology Voice Network: Dr. Ramin Farhood & Dr. Kirk Shepard

Article
Median Survival or Mean Survival: Which Measure Is the Most Appropriate for Patients, Physicians, and Policymakers?
OVN Avatar Omer Ben‐Aharon, Racheli Magnezi, Moshe Leshno, and Daniel A. Goldstein

Median Survival or Mean Survival: Which Measure Is the Most Appropriate for Patients, Physicians, and Policymakers?

Press Release
Announcing the Launch of Voices of Oncology: A Landmark Collaboration with Forbes
OVN Avatar OVN Staff

Announcing the Launch of Voices of Oncology: A Landmark Collaboration with Forbes

Press Release
Introducing OncologyVoiceNetwork.com
OVN Avatar OVN Staff

Introducing OncologyVoiceNetwork.com

Article
Updated estimates of eligibility for and response to genome-targeted oncology drugs among US cancer patients, 2006-2020
OVN Avatar A. Haslam, M.S. Kim, V. Prasad

Updated estimates of eligibility for and response to genome-targeted oncology drugs among US cancer patients, 2006-2020

Explore OVN